Skip to main content
. 2007 Aug 9;12(8):1771–1795. doi: 10.3390/12081771
1. Introduction 1772
2. Contrast Agents (CAs) for MRI: Gd-based complexes 1773
 2.1. CAs derived from acyclic ligands 1774
 2.2. CAs derived from macrocyclic ligands 1784
3. Concluding remarks and future perspectives 1790